Skip to content
Boustead
Boustead
BousteadBoustead
  • About Us
    • History of Boustead
    • Boustead Today
    • Milestones
    • Vision & Mission
    • Board of Directors
    • Leadership
      • Group
      • Operating Companies
  • Our Businesses
    • Pharmaceutical
    • Heavy Industries
    • Property & Industrial
      • Property Development
      • Property Management & Investment
      • Hotel Operations
      • Industrial
    • Trading, Finance & Investment
  • Act Responsibly
    • Corporate Governance
      • Board Charter
      • Directors’ Code of Ethics and Conduct
      • Audit Committee Terms of Reference
      • Risk Committee Terms of Reference
      • Nominating and Remuneration Committee Terms of Reference
      • CG Overview Statement
      • CG Report
      • Constitution
      • Diversity Policy
      • Senior Management Remuneration Policy
      • Directors Remuneration Policy
    • Integrity
      • Anti-Bribery and Corruption Policy Statement
      • Whistleblowing Policy
      • No Gift Policy
      • MACC Act Anti-Bribery Section
      • Corporate Liability Provision
  • Resource Centre
    • Media Releases
    • Gallery
    • Publications
      • Annual Reports
    • AGM / EGM
      • Summary Of Key Matters
      • Circular To Shareholders On RRPT
  • Contact Us
BousteadBoustead
  • About Us
    • History of Boustead
    • Boustead Today
    • Milestones
    • Vision & Mission
    • Board of Directors
    • Leadership
      • Group
      • Operating Companies
  • Our Businesses
    • Pharmaceutical
    • Heavy Industries
    • Property & Industrial
      • Property Development
      • Property Management & Investment
      • Hotel Operations
      • Industrial
    • Trading, Finance & Investment
  • Act Responsibly
    • Corporate Governance
      • Board Charter
      • Directors’ Code of Ethics and Conduct
      • Audit Committee Terms of Reference
      • Risk Committee Terms of Reference
      • Nominating and Remuneration Committee Terms of Reference
      • CG Overview Statement
      • CG Report
      • Constitution
      • Diversity Policy
      • Senior Management Remuneration Policy
      • Directors Remuneration Policy
    • Integrity
      • Anti-Bribery and Corruption Policy Statement
      • Whistleblowing Policy
      • No Gift Policy
      • MACC Act Anti-Bribery Section
      • Corporate Liability Provision
  • Resource Centre
    • Media Releases
    • Gallery
    • Publications
      • Annual Reports
    • AGM / EGM
      • Summary Of Key Matters
      • Circular To Shareholders On RRPT
  • Contact Us

Monthly Archives: June 2010

You are here:
  1. Home
  2. 2010
  3. June

Boustead Acquires Pharmaniaga for RM534 Million

Media ReleasesBy aiman.jasmin@shareinvestor.comJune 11, 2010

KUALA LUMPUR, June 11, 2010 – Boustead Holdings Berhad (Boustead Group) is set to strengthen its position in the pharmaceutical industry via the proposed acquisition of Pharmaniaga Berhad (Pharmaniaga), a member of UEM Group Berhad (UEM). The proposed exercise will involve the Boustead Group acquiring 86.81% of the issued and paid-up share capital of Pharmaniaga…

Go to Top
Boustead
  • About Us
    • History of Boustead
    • Boustead Today
    • Milestones
    • Vision & Mission
    • Board of Directors
    • Leadership
      • Group
      • Operating Companies
  • Our Businesses
    • Pharmaceutical
    • Heavy Industries
    • Property & Industrial
      • Property Development
      • Property Management & Investment
      • Hotel Operations
      • Industrial
    • Trading, Finance & Investment
  • Act Responsibly
    • Corporate Governance
      • Board Charter
      • Directors’ Code of Ethics and Conduct
      • Audit Committee Terms of Reference
      • Risk Committee Terms of Reference
      • Nominating and Remuneration Committee Terms of Reference
      • CG Overview Statement
      • CG Report
      • Constitution
      • Diversity Policy
      • Senior Management Remuneration Policy
      • Directors Remuneration Policy
    • Integrity
      • Anti-Bribery and Corruption Policy Statement
      • Whistleblowing Policy
      • No Gift Policy
      • MACC Act Anti-Bribery Section
      • Corporate Liability Provision
  • Resource Centre
    • Media Releases
    • Gallery
    • Publications
      • Annual Reports
    • AGM / EGM
      • Summary Of Key Matters
      • Circular To Shareholders On RRPT
  • Contact Us